Advertisement
AXSM vs MIRM
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AXSM is a Hold and MIRM is a StrongBuy.
AXSM sees its 50-day moving average cross bearishly below its 200-day moving average
The 50-day moving average for AXSM moved below the 200-day moving average on October 14, 2026. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.
Technical Analysis (Indicators)
Bearish Trend Analysis
The Momentum Indicator moved below the 0 level on September 18, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on AXSM as a result. In 57 of 70 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 81%.
The Moving Average Convergence Divergence Histogram (MACD) for AXSM turned negative on September 23, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 50 similar instances when the indicator turned negative. In 39 of the 50 cases the stock turned lower in the days that followed. This puts the odds of success at 78%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where AXSM declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 77%.
The Aroon Indicator for AXSM entered a downward trend on October 22, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Bullish Trend Analysis
The RSI Indicator shows that the ticker has stayed in the oversold zone for 17 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an Uptrend is expected.
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 22 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
AXSM may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
Fundamental Analysis (Ratings)
The Tickeron PE Growth Rating for this company is 16 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 38 (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock slightly better than average.
The Tickeron Price Growth Rating for this company is 65 (best 1 - 100 worst), indicating steady price growth. AXSM’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of 93 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: AXSM's P/B Ratio (98.135) is slightly higher than the industry average of (2.973). P/E Ratio (-41.619) is within average values for comparable stocks, (-1.705). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (128.121) among similar stocks. P/S Ratio (13.908) is also within normal values, averaging (438.009).
The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
MIRM in upward trend: price expected to rise as it breaks its lower Bollinger Band on September 18, 2026
MIRM may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In 34 of 37 cases where MIRM's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are 90%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where MIRM's RSI Indicator exited the oversold zone, 10 of 13 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 77%.
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 56 of 67 cases where MIRM's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 84%.
The Momentum Indicator moved above the 0 level on October 19, 2026. You may want to consider a long position or call options on MIRM as a result. In 86 of 98 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 88%.
The Moving Average Convergence Divergence (MACD) for MIRM just turned positive on October 12, 2026. Looking at past instances where MIRM's MACD turned positive, the stock continued to rise in 40 of 47 cases over the following month. The odds of a continued upward trend are 85%.
Following a +6.15% 3-day Advance, the price is estimated to grow further. Considering data from situations where MIRM advanced for three days, in 235 of 312 cases, the price rose further within the following month. The odds of a continued upward trend are 75%.
Bearish Trend Analysis
The 50-day moving average for MIRM moved below the 200-day moving average on October 02, 2026. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where MIRM declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 64%.
The Aroon Indicator for MIRM entered a downward trend on October 15, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron Valuation Rating of 1 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: MIRM's P/B Ratio (-517.738) is very low in comparison to the industry average of (2.973). P/E Ratio (-5.902) is within average values for comparable stocks, (-1.705). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (128.121) among similar stocks. P/S Ratio (8.842) is also within normal values, averaging (438.009).
The Tickeron PE Growth Rating for this company is 16 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 36 (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock slightly better than average.
The Tickeron Price Growth Rating for this company is 62 (best 1 - 100 worst), indicating steady price growth. MIRM’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
AXSM | MIRM | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 50 | 15 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 93 Overvalued | 1 Undervalued | |
PROFIT vs RISK RATING 1..100 | 38 | 36 | |
SMR RATING 1..100 | 100 | 100 | |
PRICE GROWTH RATING 1..100 | 65 | 62 | |
P/E GROWTH RATING 1..100 | 16 | 16 | |
SEASONALITY SCORE 1..100 | n/a | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
MIRM's Valuation (1) in the null industry is significantly better than the same rating for AXSM (93) in the Pharmaceuticals Other industry. This means that MIRM’s stock grew significantly faster than AXSM’s over the last 12 months.
MIRM's Profit vs Risk Rating (36) in the null industry is in the same range as AXSM (38) in the Pharmaceuticals Other industry. This means that MIRM’s stock grew similarly to AXSM’s over the last 12 months.
MIRM's SMR Rating (100) in the null industry is in the same range as AXSM (100) in the Pharmaceuticals Other industry. This means that MIRM’s stock grew similarly to AXSM’s over the last 12 months.
MIRM's Price Growth Rating (62) in the null industry is in the same range as AXSM (65) in the Pharmaceuticals Other industry. This means that MIRM’s stock grew similarly to AXSM’s over the last 12 months.
MIRM's P/E Growth Rating (16) in the null industry is in the same range as AXSM (16) in the Pharmaceuticals Other industry. This means that MIRM’s stock grew similarly to AXSM’s over the last 12 months.
| AXSM | MIRM | |
|---|---|---|
| RSI ODDS (%) | 1 day ago 90% | 1 day ago 77% |
| Stochastic ODDS (%) | 2 days ago 81% | 1 day ago 84% |
| Momentum ODDS (%) | 3 days ago 81% | 1 day ago 88% |
| MACD ODDS (%) | 1 day ago 78% | 1 day ago 85% |
| TrendWeek ODDS (%) | 1 day ago 79% | 1 day ago 81% |
| TrendMonth ODDS (%) | 1 day ago 76% | 1 day ago 67% |
| Advances ODDS (%) | N/A | 3 days ago 75% |
| Declines ODDS (%) | 1 day ago 77% | 1 day ago 64% |
| BollingerBands ODDS (%) | 1 day ago 76% | 3 days ago 90% |
| Aroon ODDS (%) | 1 day ago 78% | 1 day ago 62% |
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
AXSM’s FA Score shows that 1 FA rating(s) are green while MIRM’s FA Score has 2 green FA rating(s).
- AXSM’s FA Score: 1 green, 4 red.
- MIRM’s FA Score: 2 green, 3 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
AXSM’s TA Score shows that 3 TA indicator(s) are bullish while MIRM’s TA Score has 6 bullish TA indicator(s).
- AXSM’s TA Score: 3 bullish, 5 bearish.
- MIRM’s TA Score: 6 bullish, 3 bearish.
Price Growth
AXSM (@Biotechnology) experienced а -3.54% price change this week, while MIRM (@Biotechnology) price change was +0.86% for the same time period.
The average weekly price growth across all stocks in the @Biotechnology industry was -1.17%. For the same industry, the average monthly price growth was -18.21%, and the average quarterly price growth was -15.24%.
Reported Earning Dates
AXSM is expected to report earnings on Nov 02, 2026.
MIRM is expected to report earnings on Nov 03, 2026.
Industries' Descriptions
@Biotechnology (-1.17% weekly)Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.
Advertisement
MIRM and
Correlation & Price change
A.I.dvisor indicates that over the last year, MIRM has been loosely correlated with XERS. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if MIRM jumps, then XERS could also see price increases.
| Ticker / NAME | Correlation To MIRM | 1D Price Change % | ||
|---|---|---|---|---|
| MIRM | 100% | -0.41% | ||
| XERS - MIRM | 45% Loosely correlated | +0.70% | ||
| KURA - MIRM | 43% Loosely correlated | -0.20% | ||
| EXEL - MIRM | 42% Loosely correlated | +1.13% | ||
| PTCT - MIRM | 41% Loosely correlated | +0.67% | ||
| ORKA - MIRM | 40% Loosely correlated | +1.54% | ||
More | ||||
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| XSVN | 45.64 | 0.51 | +1.13% |
| BondBloxx Bloomberg Seven Year Target Duration US Treasury ETF (XSVN) | |||
| THRV | 23.09 | 0.01 | +0.04% |
| Prospera Income ETF (THRV) | |||
| DISV | 42.44 | -0.48 | -1.12% |
| Dimensional International Small Cap Value ETF (DISV) | |||
| QQQG | 29.60 | -1.01 | -3.29% |
| Pacer Nasdaq 100 Top 50 Cash Cows Growth Leaders ETF (QQQG) | |||
| PLTM | 15.01 | -0.61 | -3.91% |
| GraniteShares Platinum Trust (PLTM) | |||